Argentina might have the first locally-manufactured medical cannabis product as soon as early 2021. Reports Mj Biz
An official document shared by local pharmaceutical newspaper Pharmabiz shows that Manuel Limeres, head of Argentina’s National Administration of Drugs, Foods and Medical Devices (ANMAT), authorized the company Laboratorio Alef Medical Argentina to register its Convupidiol product as a medicine.
The ANMAT authorization has a validity of five years.
However, Pharmabiz General Manager Cristina Kroll told Marijuana Business Daily “the company still needs to get the approval of the first (production) batch” in order for Convipidiol to become effectively available to patients.
Read more at